CIRM / REGENERATIVE MEDICINE CONSORTIUM

Imaging Technology for Cellular Therapies

Presentations from FDA and Leading Experts

Webinar was held May 26, 2011 - see below for slides and video of the event.
Fee: None

Webinar Topic & Agenda

Imaging Technology for Cellular Therapies

• FDA’s perspective on imaging technology
  The use of imaging technology in preclinical studies to assess cell fate
• Overview of existing and new imaging technology
  Potential issues to consider with respect to different methods
• Application and translation of animal model imaging to patients

Moderator: Ellen Feigal, MD, CIRM, Vice President of Research and Development

Speakers:

• Pakwai (Patrick) Au, Ph.D., Pharmacology/Toxicology Reviewer, Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)
  see slides [pdf]
• Joseph Frank, MS, MD, Chief Frank Laboratory and Laboratory Diagnostic Radiology Research, Clinical Center, Adjunct Senior Investigator, National Institutes of Biomedical Imaging and Bioengineering
  see slides [pdf]
• Shahriar Yaghoubi, PhD, Chief Scientific Officer, CellSight Technologies, Inc., Visiting Professor, Department of Molecular and Medical Pharmacology, UCLA School of Medicine
  see slides [pdf]

Video

• Watch the Webinar